Form 4: QuidelOrtho Corp Executive Receives Stock Options and Restricted Stock Units

Philip D. McLellan, Chief Operations Officer of QuidelOrtho Corp, was granted stock options and restricted stock units on January 29, 2025.

Summary

• Philip D. McLellan, the Chief Operations Officer of QuidelOrtho Corp, received 14,693 restricted stock units and 14,692 non-qualified stock options on January 29, 2025.
• The restricted stock units will vest over three years, with 4,897 shares vesting on January 29, 2026, and the remaining 9,796 shares vesting in equal installments on January 29, 2027 and January 29, 2028.
• The non-qualified stock options have an exercise price of $43.52 and will vest over three years, with 9,794 shares vesting in equal installments on January 29, 2026 and January 29, 2027, and the remaining 4,898 shares vesting on January 29, 2028.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

This type of equity grant is a common practice for incentivizing and retaining key executives in publicly traded companies.

Comparison to Industry Standards

• Equity grants are a standard component of executive compensation packages in the healthcare and diagnostics industry.
• Companies like Abbott Laboratories, Danaher Corporation, and Thermo Fisher Scientific also use stock options and restricted stock units to incentivize their executives.
• The vesting schedules are typical for these types of grants, designed to encourage long-term performance and retention.

Stakeholder Impact

• The equity grants align the executive's interests with those of the shareholders, potentially leading to better company performance.
• The vesting schedule encourages long-term commitment from the executive, which can benefit the company and its stakeholders.

Key Dates

Keywords

stock options, restricted stock units, executive compensation, insider trading, QuidelOrtho Corp, QDEL, Philip D. McLellan